Validation of the BATT score for prehospital risk stratification of traumatic haemorrhagic death: usefulness for tranexamic acid treatment criteria (2021)
Attributed to:
The CRASH-3 Trial: Tranexamic acid for the treatment of significant traumatic brain injury.
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1186/s13049-020-00827-5
PubMed Identifier: 33407716
Publication URI: http://europepmc.org/abstract/MED/33407716
Type: Journal Article/Review
Parent Publication: Scandinavian Journal of Trauma, Resuscitation and Emergency Medicine
Issue: 1
ISSN: 1757-7241